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Abstract 
BACKGROUND: A variety of drugs can be used for the treatment of acne vulgaris. Every medicine acts against one 
or some of the mechanisms of the pathogenesis of acne vulgaris. This study was conducted to assess the 
therapeutic effect of Clinda Soap in the treatment of acne vulgaris.  
METHODS: This randomized, double-blind, clinical trial included 82 patients (age: 15-35 years) with mild to 
moderate acne vulgaris. The study protocol was approved by the ethics committee of Kurdistan University of 
Medical Sciences (Sanandaj, Iran). The patients were randomized into two groups to receive the standard 
treatment for acne vulgaris with either Clinda Soap (containing clindamycin hydrochloride 1%, manufactured by 
Shadakish Company, Iran) or a placebo soap. Both the intervention and control groups were asked to apply soaps 
twice daily for three months. Monthly examinations were performed by a dermatologist to ensure proper use of the 
soaps and to assess the rate of recovery and possible complications. Data was analyzed using repeated measures 
analysis of variance in SPSS. 
RESULTS: The mean age of patients was 21.1 ± 4.7 years in the intervention group and 21.5 ± 4.8 years in the 
control group. The mean duration of the disease was 3.0 ± 1.5 and 3.1 ± 1.8 months in the intervention and 
control groups, respectively. The mean number of comedones in the two groups had no significant difference at 
any monthly visit. In contrast, at all visits, significantly fewer papules and pustules were observed in the 
intervention group than in the control. Significant intra-group and inter-group differences in the number of 
inflammatory lesions (papules and pustules) were also seen. 
CONCLUSION: In general, it can be concluded that Clinda Soap is effective in the treatment of acne vulgaris. The 
recovery rate of papules and pustules was higher than that of comedones. Easy application of this soap together 
with its low cost and few adverse effects will increase patients' compliance. 
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Introduction1 
Acne vulgaris, a common inflammatory disease 
of pilosebaceous units, is experienced by 80% of 
adolescents. Increased sebaceous gland secretion, 




obstruction of pilosebaceous ducts, release of 
mediators of inflammation, and bacterial 
colonization are mechanisms involved in the 
pathogenesis of acne vulgaris. Propionibacterium 
acnes (P. acnes), a Gram positive anaerobic 
bacterium, is the dominant microorganism which 
colonizes pilosebaceous units.1 
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and its onset is earlier in girls.2 Its greatest 
frequency is seen in 14-17-year-old girls and  
16-19-year-old boys.3 Acne is of significance as it 
is highly prevalent in young adults and its 
complications such as scarring and poor self-
image can lead to anxiety, depression, and social 
withdrawal.4,5 
While a variety of medications are available 
for the treatment of acne, each medicine targets 
one or some of the factors involving in the 
pathogenesis of acne. They act through reversing 
hypercornification of sebaceous ducts, 
decreasing sebum production, reducing 
follicular bacteria (in particular P. acnes), or 
decreasing inflammatory mediators by inhibiting 
bacterial growth.6,7 Several topical and systemic 
medications are used for the treatment of acne. 
Systemic therapy includes antimicrobial agents, 
hormone preparations, and isotretinoin. 
Selection of therapy depends on the clinical 
variant and severity of acne and previously 
applied treatments.8-10 Although systemic and 
topical antimicrobial preparations have been 
commonly used to cure inflammatory acne,11,12 
the emergence of resistant microorganisms 
(particularly P. acnes) has caused some problems 
in the treatment of acne. Therefore, the use of 
effective non-antimicrobial preparations should 
be taken into consideration. Nicotinamide gel 
has potent anti-inflammatory properties and its 
use does not promote the emergence of resistant 
strains of microorganisms.4  
Systemic antibiotics, especially tetracycline 
have been used as the treatment of choice for the 
treatment of acne vulgaris for many years. Long-
term use of tetracycline is often associated with 
gastrointestinal complications. However, 
application of topical medications brings about 
fewer side effects.10 Evaluation of therapeutic 
responses and finding proper therapeutic 
regimens in different populations with different 
genetic and racial characteristics will be valuable 
for the treatment of acne. Since efficient 
therapeutic regimens with few side effects are 
preferred by most dermatologists, we 
investigated the effects of Clinda Soap 
(manufactured by Shadakish Co., Iran) on the 
treatment of acne vulgaris. 
Materials and Methods 
This randomized, double-blind study was 
conducted in Besat Hospital (Sanandaj, Iran) 
from August 2011 to August 2012. It included 
106 patients (age: 15-25 years) with mild to 
moderate acne vulgaris. The severity of acne 
was determined according to the Global Acne 
Grading System.13 Patients with any chronic 
disease or polycystic ovary syndrome, pregnant 
and lactating women, patients who had used 
topical or systemic antibiotics within 30 days 
before the intervention, and those using 
acnegenic drugs such as vitamin B12, steroids, 
anti-tuberculosis drugs, lithium, and phenytoin 
were excluded from the study.  
The study was approved by the ethics 
committee of Kurdistan University of Medical 
Sciences (Sanandaj, Iran). It was also registered 
at Iranian Registry of Clinical Trials (IRCT) with 
the registration number of IRCT 20100925480n1.  
After obtaining informed consent from the 
patients, block randomization was used to 
allocate the participants to either intervention 
(n = 50) or control group (n = 50). Both the 
patients and the dermatologist were blinded to 
the grouping and the appearance of the placebo 
and Clinda Soap were similar. As the standard 
acne treatment, the two groups received 250 mg 
oral tetracycline every six hours. The 
intervention group was instructed to wash the 
affected areas of the skin with warm water and 
Clinda Soap and let the lather remain on the 
skin for three minutes, twice daily, for 12 
weeks. Clinda Soap contains clindamycin 
hydrochloride 1% and has neutral pH. The 
control group was asked to perform a similar 
procedure with placebo soap. All patients were 
visited by our dermatologist every month for 
three months. Inflammatory lesions (papules 
and pustules) and non-inflammatory lesions 
(comedones) were counted and recorded at 
baseline and every visit. 
A total of 24 patients were excluded from the 
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study because of lack of cooperation, planning 
for pregnancy, and drug adverse effects. 
Finally, 82 patients (39 in the intervention 
group and 43 in the control group) completed 
the treatment course. The data was analyzed 
with SPSS for Windows (version 16.0, SPSS Inc., 
Chicago, IL, USA). Since the lesions were 
counted for four times during the treatment 
course, we used repeated measures analysis of 
variance to compare the data (The whole 
process of the study is summarized in Figure 1). 
Results 
The mean age of the intervention and control 
groups was 21.1 ± 4.7 and 21.5 ± 4.8 years, 
respectively. The two groups were similar in the 
mean duration of the disease (3.0 ± 1.5 months in 
the intervention group and 3.1 ± 1.8 months in 
the control group). Sex distribution, family 
history of acne, and severity of the disease were 
also similar in the two groups (Table 1). 
At the end of the study, there was no 
significant difference between the two groups in 
regard to the number of comedones (P = 0.85) 
(Table 2). In contrast, significantly better recovery 
rate of papules and pustules was observed in the 
intervention group (Tables 3 and 4). 
Discussion 
In our study, the intervention and control groups 
were matched for demographic characteristics 
(age, gender, occupation, and severity, duration, 
and family history of acne). Moreover, no 































Figure 1. The consort flowchart of the study  
 
Lost to follow-up (n = 10): 
Diarrhea (n = 1), skin erythema (n = 1), 
severe dryness of skin (n = 3),  
reflux (n = 2), lack of cooperation (n = 3) 
Lost to follow-up (n = 14):  
Diarrhea (n = 2), severe dryness of skin  
(n = 1), lack of cooperation (n = 6), polycystic 
ovary syndrome (n = 1), reflux (n = 3), 
planning for pregnancy (n = 1) 
Assessed for eligibility (n = 152) 
Excluded (n = 46) 
Not meeting inclusion criteria (n = 30) 
Refused to participate (n = 16) 
Other reasons (n = 0) 
Allocated to intervention (n = 53) 
Received intervention (n = 53) 
Did not receive intervention (n = 0) 
Enrollment 
Randomized (n = 106) 
Analyzed (n = 39) 
Excluded from analysis (n = 0) 
Allocated to control (n = 53) 
Received intervention (n = 0) 
Did not receive intervention (n = 53) 
Analyzed (n = 43) 
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Table 1. Demographic and disease-related characteristics of the participants 
Variables Control group Intervention group P 
Gender Male 15 (53.6) 13 (46.4 ) 0.88 Female 28 (51.9) 26 (48.1) 
Severity of acne Mild 9 (52.9) 8 (47.1) 0.96 Moderate 34 (52.3) 31 ( 47.7) 
Family history Positive 18 (51.4) 17 ( 48.6) 0.94 Negative 25 (53.2) 22 (46.8) 
Values are n (%). 
 
Table 2. The mean number of comedones in the intervention and control groups at 
different times of treatment course 
 Baseline First month Second month Third month 
Control group 12.45 ± 4.27 8.83 ± 3.46 6.29 ± 3.27 4.42 ± 2.86 
Intervention group 13.11 ± 5.01 8.91 ± 4.57 6.28 ± 3.69 4.37 ± 2.80 
 
Table 3. The mean number of papules in the intervention and control groups at 
 different times of treatment course 
 Baseline First month Second month Third month 
Control group 9.64 ± 3.83 7.05 ± 3.49 5.15 ± 2.86 2.46 ± 2.67 
Intervention group 10.40 ± 4.69 5.04 ± 3.49 2.70 ± 2.48 1.09 ± 1.51 
 
Table 4. The mean number of pustules in the intervention and control groups at 
different times of treatment course 
 Baseline First month Second month Third month 
Control group 4.16 ± 1.93 2.83 ± 1.29 2.10 ± 1.35 1.33 ± 0.99 
Intervention group 3.81 ± 1.94 1. 46 ± 1.12 0.72 ± 0.99 0.24 ± 0.49 
 
and type and number of lesions (comedones, 
inflammatory papules, and pustules) were 
detected between the two groups before the 
intervention. The two groups were not 
significantly different in the number of closed 
comedones at any of the follow-up visits. 
However, at all visits, fewer papules and 
pustules were observed in the intervention 
group than in the control group.  
Several different medications such as 
antimicrobial agents, hormone preparations, oral 
retinoids, steroids, and topical salicylic acid have 
been suggested for the treatment of acne 
vulgaris.5 In a review article, Del Rosso and 
Schmidt pointed out that the anti-inflammatory 
effect of clindamycin has received considerable 
attention as an essential mechanism for the 
treatment of acne in the last three decades.14 
Our evaluations showed that the number of 
all types of lesions had a decreasing trend in 
both groups during the treatment. Significantly 
greater reduction in the number of inflammatory 
lesions (papules and pustules) was seen in the 
intervention group. As this difference was more 
significant for pustules, it can be concluded that 
Clinda Soap was more effective in the treatment 
of pustules in comparison to other types of acne 
lesions. Contrariwise, no significant difference in 
the number of comedones was detected between 
the two groups. 
In an eight-week study, Shalita et al. found 
that nicotinamide gel and clindamycin gel did 
not cause significantly different reductions in the 
mean number of acne lesions (-14.1 vs. -12.3).10 
These findings are in accordance with the results 
of our study.  
Cunliffe et al. conducted a clinical trial to 
compare the effects of a topical 
clindamycin/zinc gel and a topical clindamycin 
lotion in 246 patients with mild to moderate 
acne. They concluded that both drugs had 
similar therapeutic effects.15 In a study in 
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Germany, Zouboulis et al. found higher and 
faster recovery after using a fixed clindamycin 
phosphate/tretinoin gel than after the 
application of a clindamycin lotion (Dalacin).16 
NilFroushzadeh et al. reported significantly 
different reduction in the severity of acne 
following the use of clindamycin phosphate and 
salicylic acid lotion, clindamycin phosphate and 
tretinoin lotion, and clindamycin lotion.17 
Pazoki-Toroudi et al. concluded that the 
combination of clindamycin and azelaic acid is 
more effective than either clindamycin or azelaic 
acid alone.18 Draelos et al. showed that use of 
clindamycin phosphate/tretinoin gel together 
with 4% benzoyl peroxide wash was effective in 
the treatment of acne. They also found good 
medication compliance in the patients with acne 
vulgaris.19 
Conclusion 
The results of this study indicated that Clinda 
Soap is effective in the treatment of lesions of 
acne vulgaris, particularly papules and pustules. 
Considering its low cost, easy use, and few side 
effects, compliance with this treatment is 
expected to be favorable. 
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